Literature DB >> 16244930

Monitoring and treatment of Fascioloides magna in semi-farm red deer husbandry in Croatia.

Z Janicki1, D Konjević, K Severin.   

Abstract

The presence of American liver fluke (Fascioloides magna) in Croatian wild ruminant species was detected for the first time in January 2000. At the same time, the problem of adequate parasitological monitoring and treatment appeared in the captive deer population. Quarantine and health screening protocols, as well as migration and transportation influence had to be evaluated in red deer husbandry. Non-invasive methods were introduced to estimate the prevalence of F. magna in the semi-farm rearing system. Coprological analysis has been performed on 264 faecal samples. The most effective antiparasitic treatment was implemented on herd and individual treatment. Treatment was extended to the free-ranging population of deer in the same region.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16244930     DOI: 10.1007/s11259-005-0027-z

Source DB:  PubMed          Journal:  Vet Res Commun        ISSN: 0165-7380            Impact factor:   2.459


  8 in total

1.  Health protocol for translocation of free-ranging elk.

Authors:  J L Corn; V F Nettles
Journal:  J Wildl Dis       Date:  2001-07       Impact factor: 1.535

2.  The efficacy of closantel against Fascioloides magna in sheep.

Authors:  B E Stromberg; J C Schlotthauer; G A Conboy
Journal:  J Parasitol       Date:  1984-06       Impact factor: 1.276

3.  [Dissemination of helminths by the introduction of game animals].

Authors:  B Kotrlá; A Kotrlý
Journal:  Angew Parasitol       Date:  1980-05

4.  Development of the large American liver fluke, Fascioloides magna, in white-tailed deer, cattle, and sheep.

Authors:  W J Foreyt; A C Todd
Journal:  J Parasitol       Date:  1976-02       Impact factor: 1.276

5.  Anthelmintic activity of albendazole in white-tailed deer.

Authors:  W J Foreyt; D L Drawe
Journal:  Am J Vet Res       Date:  1978-12       Impact factor: 1.156

6.  Efficacy of triclabendazole against natural infections of Fascioloides magna in wapiti.

Authors:  M J Pybus; D K Onderka; N Cool
Journal:  J Wildl Dis       Date:  1991-10       Impact factor: 1.535

7.  Use of bait containing triclabendazole to treat Fascioloides magna infections in free ranging white-tailed deer.

Authors:  T Qureshi; D L Drawe; D S Davis; T M Craig
Journal:  J Wildl Dis       Date:  1994-07       Impact factor: 1.535

8.  A controlled evaluation of albendazole against natural infections with Fasciola hepatica and Fascioloides magna in cattle.

Authors:  N C Ronald; T M Craig; R R Bell
Journal:  Am J Vet Res       Date:  1979-09       Impact factor: 1.156

  8 in total
  4 in total

1.  The giant liver fluke Fascioloides magna (Bassi 1875) in cervids in the Czech Republic and potential of its spreading to Germany.

Authors:  Adam Novobilský; Eva Horácková; Lenka Hirtová; David Modrý; Bretislav Koudela
Journal:  Parasitol Res       Date:  2006-10-03       Impact factor: 2.289

2.  The origin of the giant liver fluke, Fascioloides magna (Trematoda: Fasciolidae) from Croatia determined by high-resolution melting screening of mitochondrial cox1 haplotypes.

Authors:  Eva Bazsalovicsová; Ivica Králová-Hromadová; Ján Radvánszky; Relja Beck
Journal:  Parasitol Res       Date:  2013-04-23       Impact factor: 2.289

3.  Long-term follow-up after allogeneic stem cell transplantation in patients with myelodysplastic syndromes or secondary acute myeloid leukemia: a single center experience.

Authors:  Alexandra Boehm; Wolfgang R Sperr; Peter Kalhs; Hildegard Greinix; Peter Valent; Nina Worel; Alexander Kainz; Margit Mitterbauer; Marija Bojic; Werner Rabitsch
Journal:  Wien Klin Wochenschr       Date:  2013-11-19       Impact factor: 1.704

4.  The role of hepatic myofibroblasts in liver cirrhosis in fallow deer (Dama dama) naturally infected with giant liver fluke (Fascioloides magna).

Authors:  Darko Marinković; Vladimir Kukolj; Sanja Aleksić-Kovačević; Milijan Jovanović; Milijana Knežević
Journal:  BMC Vet Res       Date:  2013-03-06       Impact factor: 2.741

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.